Vimarsana
Biggest News Aggregation in the World

Page 25 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roivant Sciences Today - Breaking & Trending Today

Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs - Vimarsana News

Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs

BioPharma

2024 Presidential candidates: Republican field - Vimarsana News

2024 Presidential candidates: Republican field

Who are the 2024 Republican presidential candidates? Here’s who’s running in the U.S. election, where they stand on key issues and more

Source: cnn.com
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by Artia Global Partners LP - Vimarsana News

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by Artia Global Partners LP

Artia Global Partners LP raised its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 422.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 824,363 shares of the company’s stock after acquiring an additional 666,600 shares during the […]

Source: wkrb13.com
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes - Vimarsana News

Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes

For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.

Source: fool.com
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes - Vimarsana News

Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes

For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.

Source: fool.com